CASI Pharmaceuticals To Present At Jefferies London Healthcare Conference

Rhea-AI Summary

CASI Pharmaceuticals, a U.S. biopharmaceutical company, will have President Larry Zhang present at the upcoming Jefferies London Healthcare Conference on November 18 and 19. The presentation will be held virtually and available on-demand. This event highlights CASI's commitment to developing innovative therapeutics targeted at unmet medical needs in hematology oncology and other areas.

The company leverages its expertise in the global drug market, focusing on China as a key area for expansion.

ROCKVILLE, Md., and BEIJING, Nov. 15, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces that Mr. Larry Zhang, President of CASI Pharmaceuticals, will be presenting at the Jefferies London Healthcare Conference. Details for the virtual conference is as follows:

Jefferies London Healthcare Conference
Date: November 18^th & 19^th
Time: On-Demand

Webcast or external link of the company presentations will be available under "Events & Presentations" in the "Investors Relations" section of CASI's website. Archived replays will be available for approximately 90 days following the event.

About CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the greater China market leveraging the Company's China-based regulatory and commercial competencies and its global drug development expertise. The Company's operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd., which is located in Beijing, China. The Company has built a commercial team of more than 100 hematology oncology sales and marketing specialists based in China. More information on CASI is available at www.casipharmaceuticals.com.

COMPANY CONTACT: CASI Pharmaceuticals, Inc. 240.864.2643 ir@casipharmaceuticals.com

INVESTOR CONTACT: Bob Ai Solebury Trout 646-389-6658 bai@soleburytrout.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/casi-pharmaceuticals-to-present-at-jefferies-london-healthcare-conference-301423740.html

SOURCE CASI Pharmaceuticals, Inc.

FAQ

When is CASI Pharmaceuticals presenting at the Jefferies London Healthcare Conference?

CASI Pharmaceuticals is presenting on November 18 and 19, 2021.

Who is presenting for CASI Pharmaceuticals at the Jefferies London Healthcare Conference?

Larry Zhang, the President of CASI Pharmaceuticals, will be presenting.

Where can I watch CASI Pharmaceuticals' presentation from the Jefferies London Healthcare Conference?

The presentation will be available on-demand under 'Events & Presentations' in the Investors Relations section of CASI's website.

What is the focus of CASI Pharmaceuticals?

CASI Pharmaceuticals focuses on developing innovative therapeutics, particularly in hematology oncology and other areas of unmet medical need.

What is CASI Pharmaceuticals' strategy in China?

CASI Pharmaceuticals aims to become a leader in the Chinese market by leveraging its regulatory and commercial competencies.